Healthcare groups drug makers, device companies, insurers, and care providers under one industry-group label — not a single product cycle and not the same as a biotech index. Combined size is not a sector return. See how the ranking works.
368 U.S.-listed Healthcare companies with a market cap of at least $1B are ranked here by market capitalization, worth a combined $9.13T — 9.05% of the total market tracked on MarketCapLens. The most valuable is Eli Lilly and Company at $1.1T. As of September 22, 2026. Size ranking for research, not a sector recommendation.
| Industry | Companies | Combined cap | % of sector |
|---|---|---|---|
| Drug Manufacturers - General | 16 | $4.24T | 46.45% |
| Biotechnology | 170 | $1.24T | 13.58% |
| Medical - Diagnostics & Research | 27 | $875.8B | 9.59% |
| Medical - Devices | 39 | $757.6B | 8.30% |
| Medical - Healthcare Plans | 11 | $709.42B | 7.77% |
| Medical - Instruments & Supplies | 25 | $394.23B |
The largest company, Eli Lilly and Company (LLY), is 12.07% of Healthcare. The three largest — Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), and AbbVie Inc. (ABBV) — are 24.31% of the sector. The ten largest are 45.07%. Eli Lilly and Company is classified as Drug Manufacturers - General, which is also the largest industry in this sector by combined cap.
| Weight |
|---|
| 301 | Alphatec Holdings, Inc.ATEC | $1.59B | $10.33 | +1.57% | 1.21M | 0.02% |
| 302 | Azenta, Inc.AZTA | $1.58B | $34.28 | +1.57% | 1.1M | 0.02% |
| 303 | Maze Therapeutics, Inc.MAZE | $1.57B | $28.38 | +26.75% | 3.57M | 0.02% |
| 304 | Ardent Health Inc.ARDT | $1.57B | $10.95 | +3.20% | 504.17K | 0.02% |
| 305 | Eton Pharmaceuticals, Inc.ETON | $1.56B | $57.09 | +3.22% | 483.98K | 0.02% |
| 306 | Innoviva, Inc.INVA | $1.55B | $20.98 | -0.29% | 799.69K | 0.02% |
| 307 | Ultragenyx Pharmaceutical Inc.RARE | $1.54B | $15.62 | +6.59% | 8.12M | 0.02% |
| 308 | Kestra Medical Technologies, Ltd.KMTS | $1.53B | $26.09 | +5.33% | 281.57K | 0.02% |
| 309 | Tyra Biosciences, Inc.TYRA | $1.53B | $25.57 | -0.31% | 1.22M | 0.02% |
| 310 | Omeros CorporationOMER | $1.52B | $21.05 | +13.85% | 3.95M | 0.02% |
| 311 | Omnicell, Inc.OMCL | $1.51B | $33.17 | +2.28% | 547.19K | 0.02% |
| 312 | Xeris Biopharma Holdings, Inc.XERS | $1.51B | $8.73 | -0.80% | 1.69M | 0.02% |
| 313 | Bicara Therapeutics Inc. Common StockBCAX | $1.5B | $22.78 | +3.50% | 622.08K | 0.02% |
| 314 | Healthcare Services Group, Inc.HCSG | $1.48B | $21.57 | +1.27% | 1.42M | 0.02% |
| 315 | Ascentage Pharma Group InternationalAAPG | $1.48B | $15.87 | +0.06% | 917 | 0.02% |
| 316 | Kardigan, Inc.KARD | $1.47B | $16.44 | +0.86% | 598.21K | 0.02% |
| 317 | Agilon Health, Inc.AGL | $1.45B | $86.84 | -1.35% | 285.96K | 0.02% |
| 318 | Innovage Holding Corp.INNV | $1.45B | $10.66 | +0.52% | 282.31K | 0.02% |
| 319 | Avalyn Pharma Inc. Common StockAVLN | $1.44B | $32.45 | +2.62% | 233.28K | 0.02% |
| 320 | Nutex Health, Inc.NUTX | $1.44B | $208.82 | +3.64% | 158.2K | 0.02% |
| 321 | First Tracks Biotherapeutics IncTRAX | $1.43B | $40.97 | +5.08% | 893.14K | 0.02% |
| 322 | Phibro Animal Health CorporationPAHC | $1.42B | $35.15 | +1.36% | 169.08K | 0.02% |
| 323 | ArriVent BioPharma, Inc.AVBP | $1.41B | $30.32 | +1.95% | 389.1K | 0.02% |
| 324 | ORIC Pharmaceuticals, Inc.ORIC | $1.4B | $13.50 | +6.55% | 1.16M | 0.02% |
| 325 | CONMED CorporationCNMD | $1.38B | $46.17 | +3.31% | 441.78K | 0.02% |
| 326 | Damora Therapeutics, Inc.DMRA | $1.38B | $22.41 | -1.93% | 355.23K | 0.02% |
| 327 | Certara, Inc.CERT | $1.37B | $8.83 | +3.64% | 2.29M | 0.02% |
| 328 | The Pennant Group, Inc.PNTG | $1.37B | $39.41 | +1.16% | 232.77K | 0.02% |
| 329 | Alpha Tau Medical LtdDRTS | $1.37B | $15.14 | -2.32% | 360.36K | 0.01% |
| 330 | AMN Healthcare Services, Inc.AMN | $1.34B | $34.54 | +0.88% | 451.62K | 0.01% |
| 331 | Cullinan Therapeutics, Inc.CGEM | $1.33B | $21.67 | +1.50% | 831.81K | 0.01% |
| 332 | OPKO Health, Inc.OPK | $1.29B | $1.73 | +2.37% | 3.48M | 0.01% |
| 333 | Harrow Health, Inc.HROW | $1.28B | $34.45 | +1.56% | 428.24K | 0.01% |
| 334 | Cronos Group Inc.CRON | $1.28B | $3.43 | +3.00% | 754.75K | 0.01% |
| 335 | Omada HealthOMDA | $1.27B | $21.37 | +3.69% | 1.32M | 0.01% |
| 336 | U.S. Physical Therapy, Inc.USPH | $1.27B | $83.17 | +0.87% | 217.02K | 0.01% |
| 337 | Integra LifeSciences Holdings CorporationIART | $1.25B | $16.02 | +2.76% | 770.45K | 0.01% |
| 338 | LB Pharmaceuticals Inc Common StockLBRX | $1.22B | $42.69 | -0.70% | 244.4K | 0.01% |
| 339 | Tandem Diabetes Care, Inc.TNDM | $1.2B | $17.50 | -0.68% | 2.69M | 0.01% |
| 340 | Seaport Therapeutics, Inc. Common StockSPTX | $1.2B | $22.39 | +6.01% | 146.46K | 0.01% |
| 341 | GoodRx Holdings, Inc.GDRX | $1.19B | $3.44 | +1.47% | 910.11K | 0.01% |
| 342 | Vor Biopharma Inc.VOR | $1.19B | $22.00 | +0.50% | 2.59M | 0.01% |
| 343 | Immatics N.V.IMTX | $1.19B | $8.87 | +1.72% | 501.6K | 0.01% |
| 344 | Aktis Oncology, Inc.AKTS | $1.18B | $22.11 | +3.17% | 302.01K | 0.01% |
| 345 | Artivion, Inc.AORT | $1.17B | $24.13 | +2.12% | 605.38K | 0.01% |
| 346 | Teladoc Health, Inc.TDOC | $1.15B | $6.35 | +1.28% | 2.99M | 0.01% |
| 347 | MeiraGTx Holdings plcMGTX | $1.14B | $12.35 | -5.58% | 1.44M | 0.01% |
| 348 | Replimune Group, Inc.REPL | $1.13B | $13.47 | +4.66% | 1.53M | 0.01% |
| 349 | Corvus Pharmaceuticals, Inc.CRVS | $1.13B | $13.44 | +8.21% | 805.29K | 0.01% |
| 350 | MoonLake ImmunotherapeuticsMLTX | $1.13B | $13.38 | +6.61% | 2.26M | 0.01% |
| 351 | Odyssey Therapeutics, Inc.ODTX | $1.12B | $23.34 | +1.21% | 555.2K | 0.01% |
| 352 | MannKind CorporationMNKD | $1.11B | $3.49 | -0.29% | 16.3M | 0.01% |
| 353 | IRadimed CorporationIRMD | $1.11B | $86.51 | +4.91% | 176.51K | 0.01% |
| 354 | Savara Inc.SVRA | $1.09B | $5.30 | -2.75% | 1.41M | 0.01% |
| 355 | Alto Neuroscience, Inc.ANRO | $1.08B | $30.78 | +0.49% | 347.05K | 0.01% |
| 356 | Amphastar Pharmaceuticals, Inc.AMPH | $1.07B | $24.32 | -0.65% | 496.75K | 0.01% |
| 357 | Janux Therapeutics, Inc.JANX | $1.07B | $17.47 | +2.70% | 826.06K | 0.01% |
| 358 | Castle Biosciences, Inc.CSTL | $1.06B | $34.85 | -0.40% | 430.78K | 0.01% |
| 359 | Monte Rosa Therapeutics, Inc.GLUE | $1.06B | $12.60 | +2.77% | 1.21M | 0.01% |
| 360 | Enovis CorporationENOV | $1.06B | $18.39 | +1.94% | 1.79M | 0.01% |
| 361 | PROCEPT BioRobotics CorporationPRCT | $1.05B | $18.43 | -0.43% | 1.17M | 0.01% |
| 362 | Kura Oncology, Inc.KURA | $1.04B | $11.73 | +1.12% | 1.66M | 0.01% |
| 363 | STAAR Surgical CompanySTAA | $1.03B | $20.65 | +1.62% | 751.11K | 0.01% |
| 364 | Beta Bionics, Inc.BBNX | $1.03B | $22.81 | +3.49% | 999.58K | 0.01% |
| 365 | Jade Biosciences, Inc.JBIO | $1.02B | $16.76 | +0.12% | 643.92K | 0.01% |
| 366 | Apnimed, Inc.APMD | $1.02B | $25.51 | -2.71% | 623.91K | 0.01% |
| 367 | Lumexa Imaging Holdings, Inc. Common StockLMRI | $1.01B | $10.52 | -1.50% | 658.68K | 0.01% |
| 368 | Alumis Inc.ALMS | $1B | $8.11 | +2.66% | 2.52M | 0.01% |
| 4.32% |
| Drug Manufacturers - Specialty & Generic | 24 | $268.79B | 2.94% |
|---|
| Medical - Care Facilities | 31 | $241.82B | 2.65% |
|---|
| Other | 25 | $401.44B | 4.40% |
|---|
Read the industry rows as labeled: drug manufacturers, medical devices, diagnostics, managed care, and providers sit side by side. Combined market cap is equity size, not a health-care return, and it is not a pipeline score.